Dusseldorf - Delayed Quote EUR
OrganiGram Holdings Inc. R (0OG0.DU)
0.9050
-0.0160
(-1.74%)
At close: April 1 at 8:11:55 AM GMT+2
Loading Chart for 0OG0.DU
- Previous Close
0.9210 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 2.0000 - Volume
0 - Avg. Volume
4 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 0OG0.DU
View MorePerformance Overview: 0OG0.DU
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
0OG0.DU
38.93%
S&P/TSX Composite index (^GSPTSE)
0.37%
1-Year Return
0OG0.DU
47.51%
S&P/TSX Composite index (^GSPTSE)
12.91%
3-Year Return
0OG0.DU
47.08%
S&P/TSX Composite index (^GSPTSE)
17.60%
5-Year Return
0OG0.DU
47.08%
S&P/TSX Composite index (^GSPTSE)
71.36%
Compare To: 0OG0.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.9050
-1.74%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2340
+7.34%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2200
+15.79%
Mkt Cap EUR 74.529M
Industry Drug Manufacturers—Specialty & Generic
4.9200
+20.59%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.2200
+12.06%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.3200
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.7550
+19.84%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.53
+8.01%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.8920
-4.89%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.1550
+7.92%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4378
+12.23%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 0OG0.DU
View MoreValuation Measures
As of 4/25/2025
Market Cap
136.20M
Enterprise Value
112.74M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.96
Price/Book (mrq)
0.64
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--